Association of CYP2D6*4 Polymorphism With Response to Atorvastatin in Patients With High Low-Density Lipoprotein Level in Northern Iran, Guilan Provice
Background: People who take statins respond differently to them due to genetic differences. One of the most significant enzymes involved in drug metabolism is cytochrome P450 2D6 (CYP2D6) enzyme, coded by the CYP2D6 gene. Individuals who carry two non-functional alleles in this gene are considered a...
Saved in:
| Main Authors: | Raziyeh Asadollahpour, Faeze Khaghani, Fardin Mirbolouk, Anvarsadat Kianmehr, Omid Goodarzvand, Sara Dabirian, Mohammad Sadegh Alipour, Ehsan Zamani, Mehdi Evazalipour |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Guilan University of Medical Sciences
2023-04-01
|
| Series: | مجله دانشگاه علوم پزشکی گیلان |
| Subjects: | |
| Online Access: | http://journal.gums.ac.ir/article-1-2552-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of the binary mixtures of amlodipine and atorvastatin by chemometric-spectophotometric method
by: Hayrettin Bulum, et al.
Published: (2025-06-01) -
Lipid-lowering effectiveness of a Russian generic of atorvastatin in patients with various hyperlipidaemia phenotypes
by: P. P. Malyshev, et al.
Published: (2009-12-01) -
EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
by: A. N. Meshkov
Published: (2016-01-01) -
EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01) -
ATORVASTATIN — 20 YEARS IN THE STRUGGLE FOR LIFE
by: N. G. Gogolashvili
Published: (2018-03-01)